Meyer Handelman Company’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.8M Sell
335,549
-1,175
-0.3% -$165K 1.45% 18
2025
Q4
$41.3M Sell
336,724
-10,645
-3% -$1.29M 1.29% 21
2025
Q3
$38.6M Sell
347,369
-9,250
-3% -$1.05M 1.22% 25
2025
Q2
$39.5M Sell
356,619
-8,905
-2% -$948K 1.3% 22
2025
Q1
$41M Sell
365,524
-3,655
-1% -$377K 1.43% 18
2024
Q4
$34.1M Sell
369,179
-1,705
-0.5% -$154K 1.18% 27
2024
Q3
$31.1M Sell
370,884
-12,485
-3% -$953K 1.05% 32
2024
Q2
$26.3M Sell
383,369
-8,743
-2% -$583K 0.93% 34
2024
Q1
$28.7M Buy
392,112
+613
+0.2% +$47.1K 1.01% 32
2023
Q4
$31.7M Sell
391,499
-855
-0.2% -$66.5K 1.23% 28
2023
Q3
$29.4M Buy
392,354
+8,900
+2% +$685K 1.18% 29
2023
Q2
$29.6M Sell
383,454
-10,470
-3% -$835K 1.19% 28
2023
Q1
$32.7M Sell
393,924
-29,950
-7% -$2.48M 1.37% 22
2022
Q4
$36.4M Sell
423,874
-11,650
-3% -$923K 1.52% 17
2022
Q3
$26.9M Sell
435,524
-650
-0.1% -$41K 1.24% 23
2022
Q2
$27M Sell
436,174
-250
-0.1% -$15.5K 1.16% 27
2022
Q1
$25.9M Sell
436,424
-800
-0.2% -$51.1K 0.99% 35
2021
Q4
$31.7M Buy
437,224
+13,800
+3% +$950K 1.18% 25
2021
Q3
$29.6M Buy
423,424
+3,900
+0.9% +$274K 1.21% 25
2021
Q2
$28.9M Buy
419,524
+11,000
+3% +$735K 1.14% 29
2021
Q1
$26.4M Buy
408,524
+32,675
+9% +$2.11M 1.09% 32
2020
Q4
$21.9M Buy
375,849
+17,600
+5% +$1.06M 0.99% 37
2020
Q3
$22.6M Buy
358,249
+1,950
+0.5% +$135K 1.15% 31
2020
Q2
$27.4M Buy
356,299
+1,300
+0.4% +$99.6K 1.46% 19
2020
Q1
$26.5M Buy
354,999
+14,399
+4% +$995K 1.63% 16
2019
Q4
$22.1M Buy
340,600
+1,910
+0.6% +$124K 1.06% 32
2019
Q3
$21.5M Buy
338,690
+11,790
+4% +$771K 1.09% 33
2019
Q2
$22.1M Buy
326,900
+7,350
+2% +$484K 1.13% 30
2019
Q1
$20.6M Buy
319,550
+5,100
+2% +$339K 1.07% 33
2018
Q4
$19.7M Buy
314,450
+27,000
+9% +$1.89M 1.11% 32
2018
Q3
$22.2M Buy
287,450
+700
+0.2% +$52.9K 1.08% 35
2018
Q2
$20.3M Sell
286,750
-3,222
-1% -$228K 1.04% 35
2018
Q1
$21.9M Buy
289,972
+1,600
+0.6% +$127K 1.11% 31
2017
Q4
$20.7M Sell
288,372
-120,412
-29% -$9.14M 0.99% 35
2017
Q3
$33.1M Buy
408,784
+21,284
+5% +$1.63M 1.51% 19
2017
Q2
$27.4M Buy
387,500
+6,600
+2% +$439K 1.16% 33
2017
Q1
$25.9M Buy
380,900
+9,900
+3% +$696K 1.1% 32
2016
Q4
$26.6M Buy
371,000
+4,800
+1% +$357K 1.18% 24
2016
Q3
$29M Buy
366,200
+6,100
+2% +$496K 1.3% 23
2016
Q2
$30M Buy
360,100
+9,000
+3% +$799K 1.35% 20
2016
Q1
$32.3M Hold
351,100
1.49% 17
2015
Q4
$35.5M Sell
351,100
-1,500
-0.4% -$156K 1.68% 15
2015
Q3
$34.6M Hold
352,600
1.75% 14
2015
Q2
$41.3M Hold
352,600
1.89% 12
2015
Q1
$34.6M Hold
352,600
1.57% 15
2014
Q4
$33.2M Sell
352,600
-500
-0.1% -$51.7K 1.49% 17
2014
Q3
$37.6M Sell
353,100
-22,000
-6% -$2.15M 1.74% 16
2014
Q2
$31.1M Buy
375,100
+1,700
+0.5% +$132K 1.44% 19
2014
Q1
$26.5M Sell
373,400
-3,000
-0.8% -$235K 1.27% 21
2013
Q4
$28.3M Hold
376,400
1.37% 21
2013
Q3
$23.7M Sell
376,400
-11,000
-3% -$657K 1.26% 22
2013
Q2
$19.9M Buy
+387,400
New +$20.2M 1.09% 28

Other funds holding GILD

Meyer Handelman Company's GILD Position: Q1 2026 in Review

Meyer Handelman Company reduced its Gilead Sciences (GILD) stake by 0.35% in Q1 2026, selling an estimated $165K and leaving 335,549 shares worth $46.8M. The position accounts for 1.45% of the portfolio, ranked #18.

Meyer Handelman Company first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Meyer Handelman Company held 335,549 shares of Gilead Sciences worth $46.8M as of Q1 2026.
  • Meyer Handelman Company sold 1,175 Gilead Sciences shares in Q1 2026, an estimated $165K.
  • Gilead Sciences made up 1.45% of Meyer Handelman Company's portfolio in Q1 2026, its #18 holding.
  • Meyer Handelman Company first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Meyer Handelman Company's 13F filing for Q1 2026, filed 20 Apr 2026.